<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36233559</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5691</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11195691</ELocationID><Abstract><AbstractText>The gut has been proposed as a potential alternative entry route for SARS-CoV-2. This was mainly based on the high levels of SARS-CoV-2 receptor expressed in the gastrointestinal (GI) tract, the observations of GI disorders (such as diarrhea) in some COVID-19 patients and the detection of SARS-CoV-2 RNA in feces. However, the underlying mechanisms remain poorly understood. It has been proposed that SARS-CoV-2 can productively infect enterocytes, damaging the intestinal barrier and contributing to inflammatory response, which might lead to GI manifestations, including diarrhea. Here, we report a methodological approach to assess the evidence supporting the sequence of events driving SARS-CoV-2 enteric infection up to gut adverse outcomes. Exploring evidence permits to highlight knowledge gaps and current inconsistencies in the literature and to guide further research. Based on the current insights on SARS-CoV-2 intestinal infection and transmission, we then discuss the potential implication on clinical practice, including on long COVID. A better understanding of the GI implication in COVID-19 is still needed to improve disease management and could help identify innovative therapies or preventive actions targeting the GI tract.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clerbaux</LastName><ForeName>Laure-Alix</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0003-2707-482X</Identifier><AffiliationInfo><Affiliation>European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayasich</LastName><ForeName>Sally A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-7621-481X</Identifier><AffiliationInfo><Affiliation>University of Wisconsin-Madison Aquatic Sciences Center at US EPA, Duluth, MN 55804, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Amalia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European Commission, Joint Research Centre (JRC), 2440 Geel, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Helena</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5881-3843</Identifier><AffiliationInfo><Affiliation>Laboratory of Human Immunobiology and Pathogenesis, iNOVA4Health, Faculdade de Ci&#xea;ncias M&#xe9;dicas-Nova Medical School, Universidade Nova de Lisboa, 1099-085 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrillo</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6782-4704</Identifier><AffiliationInfo><Affiliation>Seidor Italy Srl, 20129 Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albertini</LastName><ForeName>Maria Cristina</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0003-4549-1475</Identifier><AffiliationInfo><Affiliation>Department of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanthier</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-7651-9314</Identifier><AffiliationInfo><Affiliation>Laboratory of Hepatogastroenterology, Service d'H&#xe9;pato-Gastroent&#xe9;rologie, Cliniques Universitaires Saint-Luc, UCLouvain, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grenga</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5560-1717</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement M&#xe9;dicaments et Technologies pour la Sant&#xe9;, Commissariat &#xe0; l'&#xc9;nergie Atomique et aux &#xc9;nergies Alternatives (CEA), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Universit&#xe9; Paris-Saclay, 91190 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amorim</LastName><ForeName>Maria-Joao</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-4129-6659</Identifier><AffiliationInfo><Affiliation>Instituto Gulbenkian de Ci&#xea;ncia, 2780-156 Lisbon, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cat&#xf3;lica Biomedical Research Centre, Cat&#xf3;lica Medical School, Universidade Cat&#xf3;lica Portuguesa, 1649-023 Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CEECIND/02373/2020</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e Tecnologia</Agency><Country/></Grant><Grant><GrantID>CEECIND/01049/2020</GrantID><Agency>Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e Tecnologia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">enteric infection</Keyword><Keyword MajorTopicYN="N">gastrointestinal disorders</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36233559</ArticleId><ArticleId IdType="pmc">PMC9573230</ArticleId><ArticleId IdType="doi">10.3390/jcm11195691</ArticleId><ArticleId IdType="pii">jcm11195691</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Effenberger M., Grabherr F., Mayr L., Schwaerzler J., Nairz M., Seifert M., Hilbe R., Seiwald S., Scholl-Buergi S., Fritsche G., et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020;69:1543&#x2013;1544. doi: 10.1136/gutjnl-2020-321388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321388</ArticleId><ArticleId IdType="pmc">PMC7211078</ArticleId><ArticleId IdType="pubmed">32312790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y. The characteristics of gastrointestinal symptoms in patients with severe COVID-19: A systematic review and meta-analysis. J. Gastroenterol. 2021;56:409&#x2013;420. doi: 10.1007/s00535-021-01778-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-021-01778-z</ArticleId><ArticleId IdType="pmc">PMC7987120</ArticleId><ArticleId IdType="pubmed">33759041</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Lian J.S., Hu J.H., Gao J., Zheng L., Zhang Y.M., Hao S.R., Jia H.Y., Cai H., Zhang X.L., et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69:1002&#x2013;1009. doi: 10.1136/gutjnl-2020-320926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-320926</ArticleId><ArticleId IdType="pmc">PMC7133387</ArticleId><ArticleId IdType="pubmed">32213556</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobel Y.R., Phipps M., Zucker J., Lebwohl B., Wang T.C., Sobieszczyk M.E., Freedberg D.E. Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study from the United States. Gastroenterology. 2020;159:373&#x2013;375. doi: 10.1053/j.gastro.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7152871</ArticleId><ArticleId IdType="pubmed">32294477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.S., Hung I.F.N., Chan P.P.Y., Lung K.C., Tso E., Liu R., Ng Y.Y., Chu M.Y., Chung T.W.H., Tam A.R., et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology. 2020;159:81&#x2013;95. doi: 10.1053/j.gastro.2020.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.065</ArticleId><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol H., Contreras V., Maisonnasse P., Desmons A., Delache B., Sencio V., Machelart A., Brisebarre A., Humbert L., Deryuter L., et al. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota. Gut Microbes. 2021;13:1893113. doi: 10.1080/19490976.2021.1893113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1893113</ArticleId><ArticleId IdType="pmc">PMC7951961</ArticleId><ArticleId IdType="pubmed">33685349</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Tao W., Flavell R.A., Zhu S. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat. Rev. Gastroenterol. Hepatol. 2021;18:269&#x2013;283. doi: 10.1038/s41575-021-00416-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-021-00416-6</ArticleId><ArticleId IdType="pmc">PMC7883337</ArticleId><ArticleId IdType="pubmed">33589829</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford S.E., Ramani S., Tate J.E., Parashar U.D., Svensson L., Hagbom M., Franco M.A., Greenberg H.B., O&#x2019;Ryan M., Kang G., et al. Rotavirus infection. Nat. Rev. Dis. Primers. 2017;3:17083. doi: 10.1038/nrdp.2017.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.83</ArticleId><ArticleId IdType="pmc">PMC5858916</ArticleId><ArticleId IdType="pubmed">29119972</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass R.I., Parashar U.D., Estes M.K. Norovirus Gastroenteritis. N. Engl. J. Med. 2009;361:1776&#x2013;1785. doi: 10.1056/NEJMra0804575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0804575</ArticleId><ArticleId IdType="pmc">PMC3880795</ArticleId><ArticleId IdType="pubmed">19864676</ArticleId></ArticleIdList></Reference><Reference><Citation>DuPont H.L. Acute infectious diarrhea in immunocompetent adults. N. Engl. J. Med. 2014;370:1532&#x2013;1540. doi: 10.1056/NEJMra1301069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1301069</ArticleId><ArticleId IdType="pubmed">24738670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Li F., Wei H., Lian Z.X., Sun R., Tian Z. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J. Exp. Med. 2014;211:2397&#x2013;2410. doi: 10.1084/jem.20140625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20140625</ArticleId><ArticleId IdType="pmc">PMC4235643</ArticleId><ArticleId IdType="pubmed">25366965</ArticleId></ArticleIdList></Reference><Reference><Citation>Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.Y., Loh J., Ng O.T., Marimuthu K., Ang L.W., Mak T.M., et al. Epidemiologic Features and Clinical Course of Patients Infected with SARS-CoV-2 in Singapore. JAMA. 2020;323:1488&#x2013;1494. doi: 10.1001/jama.2020.3204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3204</ArticleId><ArticleId IdType="pmc">PMC7054855</ArticleId><ArticleId IdType="pubmed">32125362</ArticleId></ArticleIdList></Reference><Reference><Citation>Shokri-Afra H., Alikhani A., Moradipoodeh B., Noorbakhsh F., Fakheri H., Moradi-Sardareh H. Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms. Sci. Rep. 2021;11:22001. doi: 10.1038/s41598-021-01231-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01231-4</ArticleId><ArticleId IdType="pmc">PMC8578669</ArticleId><ArticleId IdType="pubmed">34753964</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton G.J., Chen-Liaw A., Cossarini F., Livanos A.E., Spindler M.P., Plitt T., Eggers J., Mogno I., Gonzalez-Reiche A.S., Siu S., et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci. Rep. 2021;11:13308. doi: 10.1038/s41598-021-92740-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92740-9</ArticleId><ArticleId IdType="pmc">PMC8233421</ArticleId><ArticleId IdType="pubmed">34172783</ArticleId></ArticleIdList></Reference><Reference><Citation>Draskau M.K., Spiller C.M., Boberg J., Bowles J., Svingen T. Developmental biology meets toxicology: Contributing reproductive mechanisms to build adverse outcome pathways. Mol. Hum. Reprod. 2020;26:111&#x2013;116. doi: 10.1093/molehr/gaaa001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molehr/gaaa001</ArticleId><ArticleId IdType="pubmed">31943113</ArticleId></ArticleIdList></Reference><Reference><Citation>Siwicki A.K., Terech-Majewska E., Grudniewska J., Malaczewska J., Kazun K., Lepa A. Influence of deltamethrin on nonspecific cellular and humoral defense mechanisms in rainbow trout (Oncorhynchus mykiss) Environ. Toxicol. Chem. 2010;29:489&#x2013;491. doi: 10.1002/etc.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/etc.75</ArticleId><ArticleId IdType="pubmed">20821468</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeneuve D.L., Crump D., Garcia-Reyero N., Hecker M., Hutchinson T.H., LaLone C.A., Landesmann B., Lettieri T., Munn S., Nepelska M., et al. Adverse outcome pathway (AOP) development I: Strategies and principles. Toxicol. Sci. 2014;142:312&#x2013;320. doi: 10.1093/toxsci/kfu199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfu199</ArticleId><ArticleId IdType="pmc">PMC4318923</ArticleId><ArticleId IdType="pubmed">25466378</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeneuve D.L., Crump D., Garcia-Reyero N., Hecker M., Hutchinson T.H., LaLone C.A., Landesmann B., Lettieri T., Munn S., Nepelska M., et al. Adverse outcome pathway development II: Best practices. Toxicol. Sci. 2014;142:321&#x2013;330. doi: 10.1093/toxsci/kfu200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfu200</ArticleId><ArticleId IdType="pmc">PMC4318924</ArticleId><ArticleId IdType="pubmed">25466379</ArticleId></ArticleIdList></Reference><Reference><Citation>Users&#x2019; Handbook Supplement to the Guidance Document for Developing and Assessing Adverse Outcome Pathways. Organisation for Economic Co-operation and Development (OECD); Paris, France: 2018. (OECD Series on Adverse Outcome Pathways No. 12018).</Citation></Reference><Reference><Citation>Svingen T., Villeneuve D.L., Knapen D., Panagiotou E.M., Draskau M.K., Damdimopoulou P., O&#x2019;Brien J.M. A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation. Toxicol. Sci. 2021;184:183&#x2013;190. doi: 10.1093/toxsci/kfab113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfab113</ArticleId><ArticleId IdType="pmc">PMC8633887</ArticleId><ArticleId IdType="pubmed">34534351</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittwehr C., Amorim M.J., Clerbaux L.A., Krebs C., Landesmann B., Macmillan D.S., Nymark P., Ram R., Garcia-Reyero N., Sachana M., et al. Understanding COVID-19 through adverse outcome pathways&#x2014;2nd CIAO AOP Design Workshop. ALTEX. 2021;38:351&#x2013;357. doi: 10.14573/altex.2102221.</Citation><ArticleIdList><ArticleId IdType="doi">10.14573/altex.2102221</ArticleId><ArticleId IdType="pubmed">33677612</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux L.A., Amigo N., Amorim M.J., Bal-Price A., Batista Leite S., Beronius A., Bezemer G.F.G., Bostroem A.C., Carusi A., Coecke S., et al. COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease&#x2014;3rd CIAO AOP Design Workshop. ALTEX. 2022;39:322&#x2013;335. doi: 10.14573/altex.2112161.</Citation><ArticleIdList><ArticleId IdType="doi">10.14573/altex.2112161</ArticleId><ArticleId IdType="pmc">PMC10069302</ArticleId><ArticleId IdType="pubmed">35032963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nymark P., Sachana M., Leite S.B., Sund J., Krebs C.E., Sullivan K., Edwards S., Viviani L., Willett C., Landesmann B., et al. Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework. Front. Public Health. 2021;9:638605. doi: 10.3389/fpubh.2021.638605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.638605</ArticleId><ArticleId IdType="pmc">PMC8170012</ArticleId><ArticleId IdType="pubmed">34095051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.J., Kopetz S., Vilar E., Shen J.P., Chen K., Maitra A. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract. Genes. 2020;11:645. doi: 10.3390/genes11060645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11060645</ArticleId><ArticleId IdType="pmc">PMC7349178</ArticleId><ArticleId IdType="pubmed">32545271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler C.G.K., Allon S.J., Nyquist S.K., Mbano I.M., Miao V.N., Tzouanas C.N., Cao Y., Yousif A.S., Bals J., Hauser B.M., et al. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020;181:1016&#x2013;1035.e19. doi: 10.1016/j.cell.2020.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Kang Z., Gong H., Xu D., Wang J., Li Z., Li Z., Cui X., Xiao J., Zhan J., et al. Digestive system is a potential route of COVID-19: An analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 2020;69:1010&#x2013;1018. doi: 10.1136/gutjnl-2020-320953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-320953</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K., Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R., et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370:861&#x2013;865. doi: 10.1126/science.abd3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Thul P.J., Akesson L., Wiking M., Mahdessian D., Geladaki A., Ait Blal H., Alm T., Asplund A., Bjork L., Breckels L.M., et al. A subcellular map of the human proteome. Science. 2017;356:3321. doi: 10.1126/science.aal3321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal3321</ArticleId><ArticleId IdType="pubmed">28495876</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana S., Metz-Zumaran C., Ramirez C., Kee C., Doldan P., Shahraz M., Schraivogel D., Gschwind A.R., Sharma A.K., Steinmetz L.M., et al. Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut. Mol. Syst. Biol. 2021;17:e10232. doi: 10.15252/msb.202110232.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202110232</ArticleId><ArticleId IdType="pmc">PMC8077299</ArticleId><ArticleId IdType="pubmed">33904651</ArticleId></ArticleIdList></Reference><Reference><Citation>Beumer J., Geurts M.H., Lamers M.M., Puschhof J., Zhang J., van der Vaart J., Mykytyn A.Z., Breugem T.I., Riesebosch S., Schipper D., et al. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses. Nat. Commun. 2021;12:5498. doi: 10.1038/s41467-021-25729-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25729-7</ArticleId><ArticleId IdType="pmc">PMC8448725</ArticleId><ArticleId IdType="pubmed">34535662</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Luo R., Wang Y., Deng P., Song T., Zhang M., Wang P., Zhang X., Cui K., Tao T., et al. SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip. Sci. Bull. 2021;66:783&#x2013;793. doi: 10.1016/j.scib.2020.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scib.2020.11.015</ArticleId><ArticleId IdType="pmc">PMC7704334</ArticleId><ArticleId IdType="pubmed">33282445</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang R., Gomez Castro M.F., McCune B.T., Zeng Q., Rothlauf P.W., Sonnek N.M., Liu Z., Brulois K.F., Wang X., Greenberg H.B., et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci. Immunol. 2020;5:3582. doi: 10.1126/sciimmunol.abc3582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc3582</ArticleId><ArticleId IdType="pmc">PMC7285829</ArticleId><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Parolin C., Virtuoso S., Giovanetti M., Angeletti S., Ciccozzi M., Borsetti A. Animal Hosts and Experimental Models of SARS-CoV-2 Infection. Chemotherapy. 2021;66:8&#x2013;16. doi: 10.1159/000515341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000515341</ArticleId><ArticleId IdType="pmc">PMC8089426</ArticleId><ArticleId IdType="pubmed">33774628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L., Deng W., Huang B., Gao H., Liu J., Ren L., Wei Q., Yu P., Xu Y., Qi F., et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583:830&#x2013;833. doi: 10.1038/s41586-020-2312-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2312-y</ArticleId><ArticleId IdType="pubmed">32380511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S.H., Chen Q., Gu H.J., Yang G., Wang Y.X., Huang X.Y., Liu S.S., Zhang N.N., Li X.F., Xiong R., et al. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis. Cell Host Microbe. 2020;28:124&#x2013;133.e4. doi: 10.1016/j.chom.2020.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.020</ArticleId><ArticleId IdType="pmc">PMC7250783</ArticleId><ArticleId IdType="pubmed">32485164</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.S., Bailey A.L., Kafai N.M., Nair S., McCune B.T., Yu J., Fox J.M., Chen R.E., Earnest J.T., Keeler S.P., et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 2020;21:1327&#x2013;1335. doi: 10.1038/s41590-020-0778-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0778-2</ArticleId><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh V., Parida D., Minz A.P., Sethi M., Sahoo B.S., Senapati S. Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies. Front Pharmacol. 2020;11:579330. doi: 10.3389/fphar.2020.579330.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.579330</ArticleId><ArticleId IdType="pmc">PMC7869018</ArticleId><ArticleId IdType="pubmed">33568991</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Ven K., van Dijken H., Wijsman L., Gomersbach A., Schouten T., Kool J., Lenz S., Roholl P., Meijer A., van Kasteren P.B., et al. Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route. Front Immunol. 2021;12:750229. doi: 10.3389/fimmu.2021.750229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.750229</ArticleId><ArticleId IdType="pmc">PMC8566349</ArticleId><ArticleId IdType="pubmed">34745122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehtinen M.J., Kumar R., Zabel B., Makela S.M., Nedveck D., Tang P., Latvala S., Guery S., Budinoff C.R. The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro. iScience. 2022;25:104445. doi: 10.1016/j.isci.2022.104445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104445</ArticleId><ArticleId IdType="pmc">PMC9125999</ArticleId><ArticleId IdType="pubmed">35634575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao L., Li H., Xu J., Yang M., Ma C., Li J., Zhao S., Wang H., Yang Y., Yu W., et al. The Gastrointestinal Tract Is an Alternative Route for SARS-CoV-2 Infection in a Nonhuman Primate Model. Gastroenterology. 2021;160:1647&#x2013;1661. doi: 10.1053/j.gastro.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7725054</ArticleId><ArticleId IdType="pubmed">33307034</ArticleId></ArticleIdList></Reference><Reference><Citation>Munster V.J., Feldmann F., Williamson B.N., van Doremalen N., Perez-Perez L., Schulz J., Meade-White K., Okumura A., Callison J., Brumbaugh B., et al. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020;585:268&#x2013;272. doi: 10.1038/s41586-020-2324-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2324-7</ArticleId><ArticleId IdType="pmc">PMC7486227</ArticleId><ArticleId IdType="pubmed">32396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Baindara P., Roy D., Mandal S.M., Schrum A.G. Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis. Infect. Dis. Rep. 2022;14:243&#x2013;249. doi: 10.3390/idr14020029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr14020029</ArticleId><ArticleId IdType="pmc">PMC9024780</ArticleId><ArticleId IdType="pubmed">35447881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Lee J.Y., Yang J.S., Kim J.W., Kim V.N., Chang H. The Architecture of SARS-CoV-2 Transcriptome. Cell. 2020;181:914&#x2013;921.e10. doi: 10.1016/j.cell.2020.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.011</ArticleId><ArticleId IdType="pmc">PMC7179501</ArticleId><ArticleId IdType="pubmed">32330414</ArticleId></ArticleIdList></Reference><Reference><Citation>Amor S., Fernandez Blanco L., Baker D. Innate immunity during SARS-CoV-2: Evasion strategies and activation trigger hypoxia and vascular damage. Clin. Exp. Immunol. 2020;202:193&#x2013;209. doi: 10.1111/cei.13523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13523</ArticleId><ArticleId IdType="pmc">PMC7537271</ArticleId><ArticleId IdType="pubmed">32978971</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran A., Rosenheim J., Nageswaran G., Swadling L., Pollara G., Gupta R.K., Burton A.R., Guerra-Assuncao J.A., Woolston A., Ronel T., et al. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections. Cell. Rep. Med. 2022;3:100557. doi: 10.1016/j.xcrm.2022.100557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100557</ArticleId><ArticleId IdType="pmc">PMC8895494</ArticleId><ArticleId IdType="pubmed">35474751</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou J., Thomas P.G., Randolph A.G. Immunology of SARS-CoV-2 infection in children. Nat. Immunol. 2022;23:177&#x2013;185. doi: 10.1038/s41590-021-01123-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01123-9</ArticleId><ArticleId IdType="pmc">PMC8981222</ArticleId><ArticleId IdType="pubmed">35105983</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie M.J., Irving A.T., Forster S.C., Marsland B.J., Hansbro P.M., Hertzog P.J., Nold-Petry C.A., Nold M.F. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Sci. Immunol. 2021;6:eabd0205. doi: 10.1126/sciimmunol.abd0205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd0205</ArticleId><ArticleId IdType="pubmed">34533977</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanifer M.L., Kee C., Cortese M., Zumaran C.M., Triana S., Mukenhirn M., Kraeusslich H.G., Alexandrov T., Bartenschlager R., Boulant S. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells. Cell Rep. 2020;32:107863. doi: 10.1016/j.celrep.2020.107863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107863</ArticleId><ArticleId IdType="pmc">PMC7303637</ArticleId><ArticleId IdType="pubmed">32610043</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudewijns R., Thibaut H.J., Kaptein S.J.F., Li R., Vergote V., Seldeslachts L., Van Weyenbergh J., De Keyzer C., Bervoets L., Sharma S., et al. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat. Commun. 2020;11:5838. doi: 10.1038/s41467-020-19684-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19684-y</ArticleId><ArticleId IdType="pmc">PMC7672082</ArticleId><ArticleId IdType="pubmed">33203860</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai M., Iwatsuki-Horimoto K., Hatta M., Loeber S., Halfmann P.J., Nakajima N., Watanabe T., Ujie M., Takahashi K., Ito M., et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl. Acad. Sci. USA. 2020;117:16587&#x2013;16595. doi: 10.1073/pnas.2009799117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009799117</ArticleId><ArticleId IdType="pmc">PMC7368255</ArticleId><ArticleId IdType="pubmed">32571934</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodeifian F., Nikfarjam M., Kian N., Mohamed K., Rezaei N. The role of type I interferon in the treatment of COVID-19. J. Med. Virol. 2022;94:63&#x2013;81. doi: 10.1002/jmv.27317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27317</ArticleId><ArticleId IdType="pmc">PMC8662121</ArticleId><ArticleId IdType="pubmed">34468995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoagland D.A., Moller R., Uhl S.A., Oishi K., Frere J., Golynker I., Horiuchi S., Panis M., Blanco-Melo D., Sachs D., et al. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021;54:557&#x2013;570. doi: 10.1016/j.immuni.2021.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.01.017</ArticleId><ArticleId IdType="pmc">PMC7846242</ArticleId><ArticleId IdType="pubmed">33577760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Beumer J., van der Vaart J., Knoops K., Puschhof J., Breugem T.I., Ravelli R.B.G., Paul van Schayck J., Mykytyn A.Z., Duimel H.Q., et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50&#x2013;54. doi: 10.1126/science.abc1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Cholankeril G., Podboy A., Aivaliotis V.I., Tarlow B., Pham E.A., Spencer S.P., Kim D., Hsing A., Ahmed A. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience from California. Gastroenterology. 2020;159:775&#x2013;777. doi: 10.1053/j.gastro.2020.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.04.008</ArticleId><ArticleId IdType="pmc">PMC7194555</ArticleId><ArticleId IdType="pubmed">32283101</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D., Rajsbaum R., Shi P.Y. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020;33:108234. doi: 10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayn M., Hirschenberger M., Koepke L., Nchioua R., Straub J.H., Klute S., Hunszinger V., Zech F., Prelli Bozzo C., Aftab W., et al. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep. 2021;35:109126. doi: 10.1016/j.celrep.2021.109126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109126</ArticleId><ArticleId IdType="pmc">PMC8078906</ArticleId><ArticleId IdType="pubmed">33974846</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Shi P.Y. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2. J. Interferon Cytokine Res. 2020;40:543&#x2013;548. doi: 10.1089/jir.2020.0214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2020.0214</ArticleId><ArticleId IdType="pmc">PMC7757701</ArticleId><ArticleId IdType="pubmed">33337934</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., Zhuang M.W., Deng J., Zheng Y., Zhang J., Nan M.L., Zhang X.J., Gao C., Wang P.H. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J. Med. Virol. 2021;93:5376&#x2013;5389. doi: 10.1002/jmv.27050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H.W., Zhang H.N., Meng Q.F., Xie J., Li Y., Chen H., Zheng Y.X., Wang X.N., Qi H., Zhang J., et al. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70. Cell Mol. Immunol. 2020;17:998&#x2013;1000. doi: 10.1038/s41423-020-0514-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0514-8</ArticleId><ArticleId IdType="pmc">PMC7387808</ArticleId><ArticleId IdType="pubmed">32728199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Shi Y., Pan X., Wu S., Hou R., Zhang Y., Zhong T., Tang H., Du W., Wang L., et al. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. 2021;34:108761. doi: 10.1016/j.celrep.2021.108761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108761</ArticleId><ArticleId IdType="pmc">PMC7857071</ArticleId><ArticleId IdType="pubmed">33567255</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O&#x2019;Meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L., et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459&#x2013;468. doi: 10.1038/s41586-020-2286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., Chan J.F., Wang Y., Yuen T.T., Chai Y., Shuai H., Yang D., Hu B., Huang X., Zhang X., et al. SARS-CoV-2 Induces a More Robust Innate Immune Response and Replicates Less Efficiently Than SARS-CoV in the Human Intestines: An Ex Vivo Study with Implications on Pathogenesis of COVID-19. Cell Mol. Gastroenterol. Hepatol. 2021;11:771&#x2013;781. doi: 10.1016/j.jcmgh.2020.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2020.09.017</ArticleId><ArticleId IdType="pmc">PMC7527315</ArticleId><ArticleId IdType="pubmed">33010495</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., Chan J.F., Wang Y., Yuen T.T., Chai Y., Hou Y., Shuai H., Yang D., Hu B., Huang X., et al. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study with Implications for the Pathogenesis of COVID-19. Clin. Infect. Dis. 2020;71:1400&#x2013;1409. doi: 10.1093/cid/ciaa410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa410</ArticleId><ArticleId IdType="pmc">PMC7184390</ArticleId><ArticleId IdType="pubmed">32270184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatton C.F., Botting R.A., Duenas M.E., Haq I.J., Verdon B., Thompson B.J., Spegarova J.S., Gothe F., Stephenson E., Gardner A.I., et al. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2. Nat. Commun. 2021;12:7092. doi: 10.1038/s41467-021-27318-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27318-0</ArticleId><ArticleId IdType="pmc">PMC8651658</ArticleId><ArticleId IdType="pubmed">34876592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Manry J., Michailidis E., Hoffmann H.H., Eto S., Garcia-Prat M., et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci. Immunol. 2021;6:abl4340. doi: 10.1126/sciimmunol.abl4340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez J., Mommert M., Mouton W., Pizzorno A., Brengel-Pesce K., Mezidi M., Villard M., Lina B., Richard J.C., Fassier J.B., et al. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J. Exp. Med. 2021;218:20211211. doi: 10.1084/jem.20211211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20211211</ArticleId><ArticleId IdType="pmc">PMC8352718</ArticleId><ArticleId IdType="pubmed">34357402</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., Chen J., Ogishi M., Sabli I.K.D., Hodeib S., Korol C., et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:abd4570. doi: 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S., Fan J., Yu F., Feng B., Lou B., Zou Q., Xie G., Lin S., Wang R., Yang X., et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: Retrospective cohort study. BMJ. 2020;369:m1443. doi: 10.1136/bmj.m1443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1443</ArticleId><ArticleId IdType="pmc">PMC7190077</ArticleId><ArticleId IdType="pubmed">32317267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zheng J., Guo L., Yao H., Wang L., Xia X., Zhang W. Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis. Virus Res. 2020;289:198147. doi: 10.1016/j.virusres.2020.198147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198147</ArticleId><ArticleId IdType="pmc">PMC7455175</ArticleId><ArticleId IdType="pubmed">32866537</ArticleId></ArticleIdList></Reference><Reference><Citation>Peccia J., Zulli A., Brackney D.E., Grubaugh N.D., Kaplan E.H., Casanovas-Massana A., Ko A.I., Malik A.A., Wang D., Wang M., et al. Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics. Nat. Biotechnol. 2020;38:1164&#x2013;1167. doi: 10.1038/s41587-020-0684-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0684-z</ArticleId><ArticleId IdType="pmc">PMC8325066</ArticleId><ArticleId IdType="pubmed">32948856</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020;158:1831&#x2013;1833. doi: 10.1053/j.gastro.2020.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann M., Allers K., Heldt C., Meinhardt J., Schmidt F., Rodriguez-Sillke Y., Kunkel D., Schumann M., Bottcher C., Stahl-Hennig C., et al. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal. Immunol. 2021;14:1381&#x2013;1392. doi: 10.1038/s41385-021-00437-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00437-z</ArticleId><ArticleId IdType="pmc">PMC8379580</ArticleId><ArticleId IdType="pubmed">34420043</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Jiang X., Zhang Z., Huang S., Zhang Z., Fang Z., Gu Z., Gao L., Shi H., Mai L., et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020;69:997&#x2013;1001. doi: 10.1136/gutjnl-2020-321013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-321013</ArticleId><ArticleId IdType="pubmed">32241899</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., Moller R., Jordan T.X., Oishi K., Panis M., Sachs D., et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181:1036&#x2013;1045. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Galani I.E., Rovina N., Lampropoulou V., Triantafyllia V., Manioudaki M., Pavlos E., Koukaki E., Fragkou P.C., Panou V., Rapti V., et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison. Nat. Immunol. 2021;22:32&#x2013;40. doi: 10.1038/s41590-020-00840-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00840-x</ArticleId><ArticleId IdType="pubmed">33277638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouchka E.C., Chariker J.H., Alejandro B., Adcock R.S., Singhal R., Ramirez J., Palmer K.E., Lasnik A.B., Carrico R., Arnold F.W., et al. Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients. Sci. Rep. 2021;11:15715. doi: 10.1038/s41598-021-95197-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95197-y</ArticleId><ArticleId IdType="pmc">PMC8333042</ArticleId><ArticleId IdType="pubmed">34344959</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Shou S., Liu M., Yang Y., Kang N., Song Y., Tan D., Liu N., Wang F., Liu J., Xie Y. Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates. Front Microbiol. 2021;12:626553. doi: 10.3389/fmicb.2021.626553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.626553</ArticleId><ArticleId IdType="pmc">PMC8438334</ArticleId><ArticleId IdType="pubmed">34531831</ArticleId></ArticleIdList></Reference><Reference><Citation>Sia S.F., Yan L.M., Chin A.W.H., Fung K., Choy K.T., Wong A.Y.L., Kaewpreedee P., Perera R., Poon L.L.M., Nicholls J.M., et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583:834&#x2013;838. doi: 10.1038/s41586-020-2342-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2342-5</ArticleId><ArticleId IdType="pmc">PMC7394720</ArticleId><ArticleId IdType="pubmed">32408338</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai L., Zhong G., Yuan Q., Wen Z., Wang C., He X., Liu R., Wang J., Zhao Q., Liu Y., et al. Replication, pathogenicity, and transmission of SARS-CoV-2 in minks. Natl. Sci. Rev. 2021;8:nwaa291. doi: 10.1093/nsr/nwaa291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa291</ArticleId><ArticleId IdType="pmc">PMC7798852</ArticleId><ArticleId IdType="pubmed">34676095</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zhang Y., Guan Z., Li H., Ye M., Chen X., Shen J., Zhou Y., Shi Z.L., Zhou P., et al. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct. Target Ther. 2020;5:235. doi: 10.1038/s41392-020-00334-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00334-0</ArticleId><ArticleId IdType="pmc">PMC7545816</ArticleId><ArticleId IdType="pubmed">33037188</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanuytsel T., Tack J., Farre R. The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation. Front Nutr. 2021;8:717925. doi: 10.3389/fnut.2021.717925.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.717925</ArticleId><ArticleId IdType="pmc">PMC8427160</ArticleId><ArticleId IdType="pubmed">34513903</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuberger J., Trimpert J., Vladimirova D., Goosmann C., Lin M., Schmuck R., Mollenkopf H.J., Brinkmann V., Tacke F., Osterrieder N., et al. Epithelial response to IFN-gamma promotes SARS-CoV-2 infection. EMBO Mol. Med. 2021;13:e13191. doi: 10.15252/emmm.202013191.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013191</ArticleId><ArticleId IdType="pmc">PMC7995094</ArticleId><ArticleId IdType="pubmed">33544398</ArticleId></ArticleIdList></Reference><Reference><Citation>Sencio V., Machelart A., Robil C., Benech N., Hoffmann E., Galbert C., Deryuter L., Heumel S., Hantute-Ghesquier A., Flourens A., et al. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters. Gut Microbes. 2022;14:2018900. doi: 10.1080/19490976.2021.2018900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.2018900</ArticleId><ArticleId IdType="pmc">PMC8726722</ArticleId><ArticleId IdType="pubmed">34965194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A.C., Zhang A.J., Chan J.F., Li C., Fan Z., Liu F., Chen Y., Liang R., Sridhar S., Cai J.P., et al. Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters. Cell Rep. Med. 2020;1:100121. doi: 10.1016/j.xcrm.2020.100121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100121</ArticleId><ArticleId IdType="pmc">PMC7508015</ArticleId><ArticleId IdType="pubmed">32984855</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.F., Yuan S., Zhang A.J., Poon V.K., Chan C.C., Lee A.C., Fan Z., Li C., Liang R., Cao J., et al. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19) Clin. Infect. Dis. 2020;71:2139&#x2013;2149. doi: 10.1093/cid/ciaa644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa644</ArticleId><ArticleId IdType="pmc">PMC7314229</ArticleId><ArticleId IdType="pubmed">32472679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoel H., Heggelund L., Reikvam D.H., Stiksrud B., Ueland T., Michelsen A.E., Otterdal K., Muller K.E., Lind A., Muller F., et al. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. J. Intern. Med. 2021;289:523&#x2013;531. doi: 10.1111/joim.13178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13178</ArticleId><ArticleId IdType="pmc">PMC7536991</ArticleId><ArticleId IdType="pubmed">32976665</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad R., Patton M.J., Floyd J.L., Vieira C.P., Fortmann S., DuPont M., Harbour A., Jeremy C.S., Wright J., Lamendella R., et al. Plasma microbiome in COVID-19 subjects: An indicator of gut barrier defects and dysbiosis. bioRxiv. 2021 doi: 10.1101/2021.04.06.438634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.06.438634</ArticleId><ArticleId IdType="pmc">PMC9409329</ArticleId><ArticleId IdType="pubmed">36012406</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L.B., Dweep H., Yin X., Wang H., Damra M., Goldman A.R., Gorman N., Palmer C.S., Tang H.Y., Shaikh M.W., et al. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front Immunol. 2021;12:686240. doi: 10.3389/fimmu.2021.686240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuyama K., Tsuruta K., Takedatsu H., Yoshioka S., Morita M., Niwa M., Matsumoto S. Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19. J. Clin. Med. 2020;9:3630. doi: 10.3390/jcm9113630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9113630</ArticleId><ArticleId IdType="pmc">PMC7696882</ArticleId><ArticleId IdType="pubmed">33187280</ArticleId></ArticleIdList></Reference><Reference><Citation>Name J.J., Souza A.C.R., Vasconcelos A.R., Prado P.S., Pereira C.P.M. Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 with a Focus on Physical Tissue Barrier Integrity. Front Nutr. 2020;7:606398. doi: 10.3389/fnut.2020.606398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2020.606398</ArticleId><ArticleId IdType="pmc">PMC7750357</ArticleId><ArticleId IdType="pubmed">33365326</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaldaferri F., Ianiro G., Privitera G., Lopetuso L.R., Vetrone L.M., Petito V., Pugliese D., Neri M., Cammarota G., Ringel Y., et al. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm. Bowel. Dis. 2020;26:1306&#x2013;1314. doi: 10.1093/ibd/izaa181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izaa181</ArticleId><ArticleId IdType="pmc">PMC7454647</ArticleId><ArticleId IdType="pubmed">32720978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen T.H., Paludan S.R. Molecular pathways in virus-induced cytokine production. Microbiol. Mol. Biol. Rev. 2001;65:131&#x2013;150. doi: 10.1128/MMBR.65.1.131-150.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.65.1.131-150.2001</ArticleId><ArticleId IdType="pmc">PMC99022</ArticleId><ArticleId IdType="pubmed">11238989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezeonwumelu I.J., Garcia-Vidal E., Ballana E. JAK-STAT Pathway: A Novel Target to Tackle Viral Infections. Viruses. 2021;13:2379. doi: 10.3390/v13122379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122379</ArticleId><ArticleId IdType="pmc">PMC8704679</ArticleId><ArticleId IdType="pubmed">34960648</ArticleId></ArticleIdList></Reference><Reference><Citation>Fric J., Zelante T., Wong A.Y., Mertes A., Yu H.B., Ricciardi-Castagnoli P. NFAT control of innate immunity. Blood. 2012;120:1380&#x2013;1389. doi: 10.1182/blood-2012-02-404475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-02-404475</ArticleId><ArticleId IdType="pubmed">22611159</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockx B., Kuiken T., Herfst S., Bestebroer T., Lamers M.M., Oude Munnink B.B., de Meulder D., van Amerongen G., van den Brand J., Okba N.M.A., et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020;368:1012&#x2013;1015. doi: 10.1126/science.abb7314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb7314</ArticleId><ArticleId IdType="pmc">PMC7164679</ArticleId><ArticleId IdType="pubmed">32303590</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson C.E., Namasivayam S., Foreman T.W., Kauffman K.D., Sakai S., Dorosky D.E., Lora N.E., NIAID/DIR Tuberculosis Imaging Program. Brooks K., Potter E.L., et al. Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Sci. Immunol. 2022;2022:eabo0535. doi: 10.1126/sciimmunol.abo0535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abo0535</ArticleId><ArticleId IdType="pmc">PMC8995035</ArticleId><ArticleId IdType="pubmed">35271298</ArticleId></ArticleIdList></Reference><Reference><Citation>Zohar T., Loos C., Fischinger S., Atyeo C., Wang C., Slein M.D., Burke J., Yu J., Feldman J., Hauser B.M., et al. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell. 2020;183:1508&#x2013;1519. doi: 10.1016/j.cell.2020.10.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.052</ArticleId><ArticleId IdType="pmc">PMC7608014</ArticleId><ArticleId IdType="pubmed">33207184</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.F., Zhang A.J., Yuan S., Poon V.K., Chan C.C., Lee A.C., Chan W.M., Fan Z., Tsoi H.W., Wen L., et al. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility. Clin. Infect. Dis. 2020;71:2428&#x2013;2446. doi: 10.1093/cid/ciaa644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa644</ArticleId><ArticleId IdType="pmc">PMC7184405</ArticleId><ArticleId IdType="pubmed">32215622</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Q., Fan L., Liu W., Li J., Yue J., Wang M., Ke X., Yin Y., Chen Q., Jiang C. Direct Evidence of Active SARS-CoV-2 Replication in the Intestine. Clin. Infect. Dis. 2021;73:361&#x2013;366. doi: 10.1093/cid/ciaa925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa925</ArticleId><ArticleId IdType="pmc">PMC7454471</ArticleId><ArticleId IdType="pubmed">32638022</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy K., Agarwal S., Banerjee R., Paul M.K., Purbey P.K. COVID-19 and gut immunomodulation. World J. Gastroenterol. 2021;27:7925&#x2013;7942. doi: 10.3748/wjg.v27.i46.7925.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i46.7925</ArticleId><ArticleId IdType="pmc">PMC8678818</ArticleId><ArticleId IdType="pubmed">35046621</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Long X., Xu Q., Tan J., Wang G., Cao Y., Wei J., Luo H., Zhu H., Huang L., et al. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol. Immunol. 2020;17:992&#x2013;994. doi: 10.1038/s41423-020-0492-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0492-x</ArticleId><ArticleId IdType="pmc">PMC7332851</ArticleId><ArticleId IdType="pubmed">32620787</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N., Sippel K., Heni M., Fritsche A., Wagner R., Jakob C.E.M., Preissl H., von Werder A., Khodamoradi Y., Borgmann S., et al. Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry. Front Med. 2022;9:875430. doi: 10.3389/fmed.2022.875430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.875430</ArticleId><ArticleId IdType="pmc">PMC9131026</ArticleId><ArticleId IdType="pubmed">35646955</ArticleId></ArticleIdList></Reference><Reference><Citation>Winer D.A., Luck H., Tsai S., Winer S. The Intestinal Immune System in Obesity and Insulin Resistance. Cell Metab. 2016;23:413&#x2013;426. doi: 10.1016/j.cmet.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.01.003</ArticleId><ArticleId IdType="pubmed">26853748</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco N., Noti M. The aging gut microbiome and its impact on host immunity. Genes Immun. 2021;22:289&#x2013;303. doi: 10.1038/s41435-021-00126-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41435-021-00126-8</ArticleId><ArticleId IdType="pmc">PMC8054695</ArticleId><ArticleId IdType="pubmed">33875817</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin A.W.H., Chu J.T.S., Perera M.R.A., Hui K.P.Y., Yen H.-L., Chan M.C.W., Peiris M., Poon L.L.M. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020;1:e10. doi: 10.1016/S2666-5247(20)30003-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30003-3</ArticleId><ArticleId IdType="pmc">PMC7214863</ArticleId><ArticleId IdType="pubmed">32835322</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li C., Zhao G., Chu H., Wang D., Yan H.H., Poon V.K., Wen L., Wong B.H., Zhao X., et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci. Adv. 2017;3:eaao4966. doi: 10.1126/sciadv.aao4966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aao4966</ArticleId><ArticleId IdType="pmc">PMC5687858</ArticleId><ArticleId IdType="pubmed">29152574</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlow J., Dallner M., Nasheri N. Protective Effect of Food Against Inactivation of Human Coronavirus OC43 by Gastrointestinal Fluids. Food Environ. Virol. 2022;14:212&#x2013;216. doi: 10.1007/s12560-022-09520-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12560-022-09520-5</ArticleId><ArticleId IdType="pmc">PMC8941299</ArticleId><ArticleId IdType="pubmed">35320506</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.W., Ha E.K., Yeniova A.O., Moon S.Y., Kim S.Y., Koh H.Y., Yang J.M., Jeong S.J., Moon S.J., Cho J.Y., et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: A nationwide cohort study with propensity score matching. Gut. 2021;70:76&#x2013;84. doi: 10.1136/gutjnl-2020-322248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322248</ArticleId><ArticleId IdType="pubmed">32732368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose R., Nakaya T., Naito Y., Daidoji T., Watanabe Y., Yasuda H., Konishi H., Itoh Y. Mechanism of Human Influenza Virus RNA Persistence and Virion Survival in Feces: Mucus Protects Virions from Acid and Digestive Juices. J. Infect. Dis. 2017;216:105&#x2013;109. doi: 10.1093/infdis/jix224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix224</ArticleId><ArticleId IdType="pubmed">28498998</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrillo M., Brogna C., Cristoni S., Querci M., Piazza O., Van den Eede G. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology. F1000Research. 2021;10:370. doi: 10.12688/f1000research.52540.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52540.1</ArticleId><ArticleId IdType="pmc">PMC8283343</ArticleId><ArticleId IdType="pubmed">34336189</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C., Brogna B., Bisaccia D.R., Lauritano F., Marino G., Montano L., Cristoni S., Prisco M., Piscopo M. Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages? Vaccines. 2022;10:708. doi: 10.3390/vaccines10050708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050708</ArticleId><ArticleId IdType="pmc">PMC9143435</ArticleId><ArticleId IdType="pubmed">35632464</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrillo M., Querci M., Brogna C., Ponti J., Cristoni S., Markov P.V., Valsesia A., Leoni G., Benedetti A., Wiss T., et al. Evidence of SARS-CoV-2 bacteriophage potential in human gut microbiota. F1000Research. 2022;11:292. doi: 10.12688/f1000research.109236.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.109236.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Hong J., Xu X., Feng Q., Zhang D., Gu Y., Shi J., Zhao S., Liu W., Wang X., et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat. Med. 2017;23:859&#x2013;868. doi: 10.1038/nm.4358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4358</ArticleId><ArticleId IdType="pubmed">28628112</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldera-Crespo L.A., Paidas M.J., Roy S., Schulman C.I., Kenyon N.S., Daunert S., Jayakumar A.R. Experimental Models of COVID-19. Front Cell Infect. Microbiol. 2021;11:792584. doi: 10.3389/fcimb.2021.792584.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.792584</ArticleId><ArticleId IdType="pmc">PMC8791197</ArticleId><ArticleId IdType="pubmed">35096645</ArticleId></ArticleIdList></Reference><Reference><Citation>Port J.R., Adney D.R., Schwarz B., Schulz J.E., Sturdevant D.E., Smith B.J., Avanzato V.A., Holbrook M.G., Purushotham J.N., Stromberg K.A., et al. Western diet increases COVID-19 disease severity in the Syrian hamster. bioRxiv. 2021 doi: 10.1101/2021.06.17.448814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.17.448814</ArticleId><ArticleId IdType="pmc">PMC8703573</ArticleId><ArticleId IdType="pubmed">34960775</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsson H.E., Rodriguez-Pineiro A.M., Schutte A., Ermund A., Boysen P., Bemark M., Sommer F., Backhed F., Hansson G.C., Johansson M.E. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 2015;16:164&#x2013;177. doi: 10.15252/embr.201439263.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201439263</ArticleId><ArticleId IdType="pmc">PMC4328744</ArticleId><ArticleId IdType="pubmed">25525071</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira-Rosario A., Marques C., Pinheiro H., Araujo J.R., Ribeiro P., Rocha R., Mota I., Pestana D., Ribeiro R., Pereira A., et al. Gut Microbiota Diversity and C-Reactive Protein Are Predictors of Disease Severity in COVID-19 Patients. Front Microbiol. 2021;12:705020. doi: 10.3389/fmicb.2021.705020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.705020</ArticleId><ArticleId IdType="pmc">PMC8326578</ArticleId><ArticleId IdType="pubmed">34349747</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux L.A., Albertini M.C., Amigo N., Beronius A., Bezemer G.F.G., Coecke S., Daskalopoulos E.P., Del Giudice G., Greco D., Grenga L., et al. Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework. J. Clin. Med. 2022;11:4464. doi: 10.3390/jcm11154464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154464</ArticleId><ArticleId IdType="pmc">PMC9369763</ArticleId><ArticleId IdType="pubmed">35956081</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerrada-Romero C., Berastegui-Cabrera J., Camacho-Martinez P., Goikoetxea-Aguirre J., Perez-Palacios P., Santibanez S., Jose Blanco-Vidal M., Valiente A., Alba J., Rodriguez-Alvarez R., et al. Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19. Sci. Rep. 2022;12:7397. doi: 10.1038/s41598-022-11439-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11439-7</ArticleId><ArticleId IdType="pmc">PMC9070969</ArticleId><ArticleId IdType="pubmed">35513481</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Muller M.A., Niemeyer D., Jones T.C., Vollmar P., Rothe C., et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465&#x2013;469. doi: 10.1038/s41586-020-2196-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2196-x</ArticleId><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong H.W., Kim S.M., Kim H.S., Kim Y.I., Kim J.H., Cho J.Y., Kim S.H., Kang H., Kim S.G., Park S.J., et al. Viable SARS-CoV-2 in various specimens from COVID-19 patients. Clin. Microbiol. Infect. 2020;26:1520&#x2013;1524. doi: 10.1016/j.cmi.2020.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.020</ArticleId><ArticleId IdType="pmc">PMC7375961</ArticleId><ArticleId IdType="pubmed">32711057</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Li T., Deng Y., Liu S., Zhang D., Li H., Wang X., Jia L., Han J., Bei Z., et al. Stability of SARS-CoV-2 on environmental surfaces and in human excreta. J. Hosp. Infect. 2021;107:105&#x2013;107. doi: 10.1016/j.jhin.2020.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2020.10.021</ArticleId><ArticleId IdType="pmc">PMC7603996</ArticleId><ArticleId IdType="pubmed">33137445</ArticleId></ArticleIdList></Reference><Reference><Citation>Dergham J., Delerce J., Bedotto M., La Scola B., Moal V. Isolation of Viable SARS-CoV-2 Virus from Feces of an Immunocompromised Patient Suggesting a Possible Fecal Mode of Transmission. J. Clin. Med. 2021;10:2696. doi: 10.3390/jcm10122696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10122696</ArticleId><ArticleId IdType="pmc">PMC8235306</ArticleId><ArticleId IdType="pubmed">34207314</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendenhall I.H., Kerimbayev A.A., Strochkov V.M., Sultankulova K.T., Kopeyev S.K., Su Y.C.F., Smith G.J.D., Orynbayev M.B. Discovery and Characterization of Novel Bat Coronavirus Lineages from Kazakhstan. Viruses. 2019;11:356. doi: 10.3390/v11040356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11040356</ArticleId><ArticleId IdType="pmc">PMC6521082</ArticleId><ArticleId IdType="pubmed">30999711</ArticleId></ArticleIdList></Reference><Reference><Citation>Temmam S., Vongphayloth K., Baquero E., Munier S., Bonomi M., Regnault B., Douangboubpha B., Karami Y., Chretien D., Sanamxay D., et al. Bat coronaviruses related to SARS-CoV-2 and infectious for human cells. Nature. 2022;604:330&#x2013;336. doi: 10.1038/s41586-022-04532-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04532-4</ArticleId><ArticleId IdType="pubmed">35172323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemian N., Kao D., Pakpour S. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic. Int. J. Mol. Sci. 2021;22:4. doi: 10.3390/ijms22063004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063004</ArticleId><ArticleId IdType="pmc">PMC7998826</ArticleId><ArticleId IdType="pubmed">33809421</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed W., Angel N., Edson J., Bibby K., Bivins A., O&#x2019;Brien J.W., Choi P.M., Kitajima M., Simpson S.L., Li J., et al. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community. Sci. Total Environ. 2020;728:138764. doi: 10.1016/j.scitotenv.2020.138764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.138764</ArticleId><ArticleId IdType="pmc">PMC7165106</ArticleId><ArticleId IdType="pubmed">32387778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawlik B., Tavazzi S., Mariani G., Skejo H., Sponar M., Higgins T., Medema G., Wintgens T. SARS-CoV-2 Surveillance Employing Sewage: Towards a Sentinel System. Publications Office of the European Union; Luxembourg: 2021.</Citation></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E.F., Vance S.E., Dahlen A., Hedlin H., Park R.M., Han A., Schmidtke D.T., Verma R., et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371&#x2013;387.e9. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura F., Kitajima M., Omori R. Duration of SARS-CoV-2 viral shedding in faeces as a parameter for wastewater-based epidemiology: Re-analysis of patient data using a shedding dynamics model. Sci. Total. Environ. 2021;769:144549. doi: 10.1016/j.scitotenv.2020.144549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2020.144549</ArticleId><ArticleId IdType="pmc">PMC7833251</ArticleId><ArticleId IdType="pubmed">33477053</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Zhu H., Ye H., Hu Y., Zheng N., Huang Z., Xiong Z., Fu L., Cai T. Risk factors for prolonged virus shedding of respiratory tract and fecal in adults with severe acute respiratory syndrome coronavirus-2 infection. J. Clin. Lab. Anal. 2021;35:e23923. doi: 10.1002/jcla.23923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23923</ArticleId><ArticleId IdType="pmc">PMC8418473</ArticleId><ArticleId IdType="pubmed">34390043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng T., Yang C., Wang H.Y., Chen X., Yu L., Wu Z.L., Sun H. Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China. J. Med. Virol. 2020;92:2735&#x2013;2741. doi: 10.1002/jmv.26146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26146</ArticleId><ArticleId IdType="pmc">PMC7300864</ArticleId><ArticleId IdType="pubmed">32510173</ArticleId></ArticleIdList></Reference><Reference><Citation>Schettino M., Pellegrini L., Picascia D., Saibeni S., Bezzio C., Bini F., Omazzi B.F., Devani M., Arena I., Bongiovanni M., et al. Clinical Characteristics of COVID-19 Patients with Gastrointestinal Symptoms in Northern Italy: A Single-Center Cohort Study. Am. J. Gastroenterol. 2021;116:306&#x2013;310. doi: 10.14309/ajg.0000000000000965.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000965</ArticleId><ArticleId IdType="pubmed">33009054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanthier N., Mahiat C., Henrard S., Starkel P., Gilard I., De Brauwer I., Cornette P., Boland B. Gastro-intestinal symptoms are associated with a lower in-hospital mortality rate in frail older patients hospitalized for COVID-19. Acta Gastroenterol. Belg. 2021;84:135&#x2013;136. doi: 10.51821/84.1.824.</Citation><ArticleIdList><ArticleId IdType="doi">10.51821/84.1.824</ArticleId><ArticleId IdType="pubmed">33639706</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares R.C.M., Mattos L.R., Raposo L.M. Risk Factors for Hospitalization and Mortality due to COVID-19 in Espirito Santo State, Brazil. Am. J. Trop. Med. Hyg. 2020;103:1184&#x2013;1190. doi: 10.4269/ajtmh.20-0483.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0483</ArticleId><ArticleId IdType="pmc">PMC7470570</ArticleId><ArticleId IdType="pubmed">32682453</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Cui M., Yang T., Yao P. Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: A systematic review and meta-analysis. BMJ Open Gastroenterol. 2020;7:e000437. doi: 10.1136/bmjgast-2020-000437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2020-000437</ArticleId><ArticleId IdType="pmc">PMC7359194</ArticleId><ArticleId IdType="pubmed">32665397</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao R., Qiu Y., He J.S., Tan J.Y., Li X.H., Liang J., Shen J., Zhu L.R., Chen Y., Iacucci M., et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2020;5:667&#x2013;678. doi: 10.1016/S2468-1253(20)30126-6. Correction to Lancet Gastroenterol. Hepatol. 2020, 5, 625&#x2013;710.e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30126-6</ArticleId><ArticleId IdType="pmc">PMC7217643</ArticleId><ArticleId IdType="pubmed">32405603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Y., Li J., Shen L., Zou Y., Hou L., Zhu L., Faden H.S., Tang Z., Shi M., Jiao N., et al. Enteric involvement in hospitalised patients with COVID-19 outside Wuhan. Lancet Gastroenterol. Hepatol. 2020;5:534&#x2013;535. doi: 10.1016/S2468-1253(20)30118-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30118-7</ArticleId><ArticleId IdType="pmc">PMC7159861</ArticleId><ArticleId IdType="pubmed">32304638</ArticleId></ArticleIdList></Reference><Reference><Citation>Chidambaram V., Tun N.L., Haque W.Z., Majella M.G., Sivakumar R.K., Kumar A., Hsu A.T., Ishak I.A., Nur A.A., Ayeh S.K., et al. Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis. PLoS ONE. 2020;15:e0241541. doi: 10.1371/journal.pone.0241541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241541</ArticleId><ArticleId IdType="pmc">PMC7673562</ArticleId><ArticleId IdType="pubmed">33206661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudatsir M., Fajar J.K., Wulandari L., Soegiarto G., Ilmawan M., Purnamasari Y., Mahdi B.A., Jayanto G.D., Suhendra S., Setianingsih Y.A., et al. Predictors of COVID-19 severity: A systematic review and meta-analysis. F1000Research. 2020;9:1107. doi: 10.12688/f1000research.26186.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.26186.1</ArticleId><ArticleId IdType="pmc">PMC7607482</ArticleId><ArticleId IdType="pubmed">33163160</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig C.J., Sutherland L.R., Sandham J.D., Fick G.H., Verhoef M., Meddings J.B. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am. J. Respir. Crit. Care Med. 1998;158:444&#x2013;451. doi: 10.1164/ajrccm.158.2.9710092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.158.2.9710092</ArticleId><ArticleId IdType="pubmed">9700119</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine Storm. N. Engl. J. Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulchandani R., Lyngdoh T., Kakkar A.K. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur. J. Clin. Investig. 2021;51:e13429. doi: 10.1111/eci.13429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13429</ArticleId><ArticleId IdType="pmc">PMC7646004</ArticleId><ArticleId IdType="pubmed">33058143</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee S.H. Lipopolysaccharide: Basic biochemistry, intracellular signaling, and physiological impacts in the gut. Intest. Res. 2014;12:90&#x2013;95. doi: 10.5217/ir.2014.12.2.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2014.12.2.90</ArticleId><ArticleId IdType="pmc">PMC4204704</ArticleId><ArticleId IdType="pubmed">25349574</ArticleId></ArticleIdList></Reference><Reference><Citation>Openshaw P.J. Crossing barriers: Infections of the lung and the gut. Mucosal. Immunol. 2009;2:100&#x2013;102. doi: 10.1038/mi.2008.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2008.79</ArticleId><ArticleId IdType="pmc">PMC7100545</ArticleId><ArticleId IdType="pubmed">19129753</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale V., Capurso G., Ianiro G., Gasbarrini A., Arcidiacono P.G., Alvaro D. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Dig. Liver. Dis. 2020;52:1383&#x2013;1389. doi: 10.1016/j.dld.2020.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.09.009</ArticleId><ArticleId IdType="pmc">PMC7494274</ArticleId><ArticleId IdType="pubmed">33023827</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignesh R., Swathirajan C.R., Tun Z.H., Rameshkumar M.R., Solomon S.S., Balakrishnan P. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm? Front Immunol. 2020;11:607734. doi: 10.3389/fimmu.2020.607734.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.607734</ArticleId><ArticleId IdType="pmc">PMC7868418</ArticleId><ArticleId IdType="pubmed">33569053</ArticleId></ArticleIdList></Reference><Reference><Citation>Venzon M., Bernard-Raichon L., Klein J., Axelrad J.E., Zhang C., Hussey G.A., Sullivan A.P., Casanovas-Massana A., Noval M.G., Valero-Jimenez A.M., et al. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation. bioRxiv. 2022 doi: 10.1101/2021.07.15.452246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.15.452246</ArticleId><ArticleId IdType="pmc">PMC9626559</ArticleId><ArticleId IdType="pubmed">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Manna S., Baindara P., Mandal S.M. Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2. J. Infect. Public Health. 2020;13:1397&#x2013;1404. doi: 10.1016/j.jiph.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7359806</ArticleId><ArticleId IdType="pubmed">32712106</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoni L., Nuding S., Wehkamp J., Stange E.F. Intestinal barrier in inflammatory bowel disease. World J. Gastroenterol. 2014;20:1165&#x2013;1179. doi: 10.3748/wjg.v20.i5.1165.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i5.1165</ArticleId><ArticleId IdType="pmc">PMC3921501</ArticleId><ArticleId IdType="pubmed">24574793</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpin W., Lee S.H., Raygoza Garay J.A., Madsen K.L., Meddings J.B., Bedrani L., Power N., Espin-Garcia O., Xu W., Smith M.I., et al. Increased Intestinal Permeability Is Associated with Later Development of Crohn&#x2019;s Disease. Gastroenterology. 2020;159:2092&#x2013;2100. doi: 10.1053/j.gastro.2020.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.08.005</ArticleId><ArticleId IdType="pubmed">32791132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollander D., Vadheim C.M., Brettholz E., Petersen G.M., Delahunty T., Rotter J.I. Increased intestinal permeability in patients with Crohn&#x2019;s disease and their relatives. A possible etiologic factor. Ann. Intern. Med. 1986;105:883&#x2013;885. doi: 10.7326/0003-4819-105-6-883.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-105-6-883</ArticleId><ArticleId IdType="pubmed">3777713</ArticleId></ArticleIdList></Reference><Reference><Citation>May G.R., Sutherland L.R., Meddings J.B. Is small intestinal permeability really increased in relatives of patients with Crohn&#x2019;s disease? Gastroenterology. 1993;104:1627&#x2013;1632. doi: 10.1016/0016-5085(93)90638-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0016-5085(93)90638-S</ArticleId><ArticleId IdType="pubmed">8500719</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrieta M.C., Madsen K., Doyle J., Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut. 2009;58:41&#x2013;48. doi: 10.1136/gut.2008.150888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2008.150888</ArticleId><ArticleId IdType="pmc">PMC2597688</ArticleId><ArticleId IdType="pubmed">18829978</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Micco S., Musella S., Sala M., Scala M.C., Andrei G., Snoeck R., Bifulco G., Campiglia P., Fasano A. Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation. Int. J. Mol. Sci. 2021;22:9427. doi: 10.3390/ijms22179427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179427</ArticleId><ArticleId IdType="pmc">PMC8431481</ArticleId><ArticleId IdType="pubmed">34502335</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S., Lau L.H., Chanchlani N., Kennedy N.A., Ng S.C. Recent advances in clinical practice: Management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2022;71:1426&#x2013;1439. doi: 10.1136/gutjnl-2021-326784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326784</ArticleId><ArticleId IdType="pmc">PMC9185820</ArticleId><ArticleId IdType="pubmed">35477864</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L., Guo F., Zhang X., Luo R., Huang C., et al. Alterations of the Gut Microbiota in Patients with Coronavirus Disease 2019 or H1N1 Influenza. Clin. Infect. Dis. 2020;71:2669&#x2013;2678. doi: 10.1093/cid/ciaa709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients with COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Venzon M., Bernard-Raichon L., Klein J., Axelrad J., Hussey G., Sullivan A., Casanovas-Massana A., Noval M., Valero-Jimenez A., Gago J., et al. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation. Res. Sq. 2021 doi: 10.21203/rs.3.rs-726620/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-726620/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerbaux L.-A., Fillipovska J., Mu&#xf1;oz A., Petrillo M., Coecke S., Amorim M.-J., Grenga L. Mechanisms leading to gut dysbiosis in COVID-19: Current evidence and uncertainties based on putative adverse outcome pathways. J. Clin. Med. 2022:Submitted. doi: 10.3390/jcm11185400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11185400</ArticleId><ArticleId IdType="pmc">PMC9505288</ArticleId><ArticleId IdType="pubmed">36143044</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Wang J., Li F., Shi Y. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections. Front Microbiol. 2020;11:1302. doi: 10.3389/fmicb.2020.01302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01302</ArticleId><ArticleId IdType="pmc">PMC7291771</ArticleId><ArticleId IdType="pubmed">32582134</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint B., Raffael B., Petrillo M., Puertas Gallardo A., Munoz-Pineiro A., Patak Dennstedt A., Querci M. Relationship between the Gut Microbiome and Diseases, Including COVID-19. Publications Office of the European Union; Luxembourg: 2021. JRC125924.</Citation><ArticleIdList><ArticleId IdType="doi">10.2760/54454</ArticleId></ArticleIdList></Reference><Reference><Citation>Baindara P., Chakraborty R., Holliday Z.M., Mandal S.M., Schrum A.G. Oral probiotics in coronavirus disease 2019: Connecting the gut-lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials. New Microbes New Infect. 2021;40:100837. doi: 10.1016/j.nmni.2021.100837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2021.100837</ArticleId><ArticleId IdType="pmc">PMC7785423</ArticleId><ArticleId IdType="pubmed">33425362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan S., Altayar O., Siddique S.M., Davitkov P., Feuerstein J.D., Lim J.K., Falck-Ytter Y., El-Serag H.B., AGA Institute AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020;159:320&#x2013;334.e27. doi: 10.1053/j.gastro.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7212965</ArticleId><ArticleId IdType="pubmed">32407808</ArticleId></ArticleIdList></Reference><Reference><Citation>El Ouali S., Achkar J.P., Lashner B., Regueiro M. Gastrointestinal manifestations of COVID-19. Cleve Clin. J. Med. 2021 doi: 10.3949/ccjm.87a.ccc049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.87a.ccc049</ArticleId><ArticleId IdType="pubmed">32554734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., Yin H., Xiao Q., Tang Y., Qu X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020;5:434&#x2013;435. doi: 10.1016/S2468-1253(20)30083-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F., Gemelli Against C.-P.-A.C.S.G. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., Rossler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163:495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D., Castro K., Schwarz S., Vaidy K., Rabinowitz S., Wallach T. Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection. JPGN Rep. 2022;3:e152. doi: 10.1097/PG9.0000000000000152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PG9.0000000000000152</ArticleId><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., Tien T.Z., Lim J.C.T., Lee J.N., Tan B., Tay Z.E.A., Wan W.Y., Chen E.X., et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Coronavirus &#x2018;ghosts&#x2019; found lingering in the gut. Nature. 2022;605:408&#x2013;409. doi: 10.1038/d41586-022-01280-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01280-3</ArticleId><ArticleId IdType="pubmed">35546630</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E., Israelow B., Mirza H., Zhao J., Qu R., Kaffe E., Song E., Halene S., Meffre E., Kluger Y., et al. A humanized mouse model of chronic COVID-19. Nat. Biotechnol. 2022;40:906&#x2013;920. doi: 10.1038/s41587-021-01155-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01155-4</ArticleId><ArticleId IdType="pmc">PMC9203605</ArticleId><ArticleId IdType="pubmed">34921308</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., Panis M., Zimering J., Horiuchi S., Hoagland D.A., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Sci. Transl. Med. 2022;2022:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Coronavirus Disease (COVID-19): Post COVID-19 Condition.  [(accessed on 15 June 2022)].  Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)  Long COVID or Post-COVID Conditions.  [(accessed on 15 June 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>